InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+36.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Erdogan-Trinkaus Ipek, Directeur Commercial. Officer active across 1 company, notably Eton Pharmaceuticals, Inc.. Cumulatively, 2 reports have been recorded. History available since 12 December 2025. The latest transaction was disclosed on 12 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
85 shares@ US$16.9050.0% of flowCommon StockSEC:0001437749-25-037747
85 shares@ US$16.900.0001% mcap50.0% of flowCommon StockSEC:0001437749-25-037747:0
2 of 2 declarations
